← All Bone Biologics CORP filings

Bone Biologics CORP S-1 registration statements

Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.

NASDAQ
BBLG
Bone Biologics CORP
S-1: Bone Biologics Launches Public Offering to Fund Clinical Trials Amidst Going Concern Doubts
Bone Biologics Corporation announced a public offering of common stock and warrants to raise approximately $4.3 million, aiming to fund clinical trials and patent portfolio expansion, while acknowledging substantial doubt about its ability to continue as a going concern.
NASDAQ
BBLG
Bone Biologics CORP
S-1/A: Bone Biologics Files Amendment No. 2 to Form S-1 Registration Statement, Updates Exhibits
Bone Biologics Corporation files an amendment to its S-1 registration statement, primarily to include updated exhibits related to an engagement agreement with H.C. Wainwright & Co., LLC.
NASDAQ
BBLG
Bone Biologics CORP
S-1/A: Bone Biologics Eyes $10.375 Million Capital Raise Through Securities Offering
Bone Biologics Corporation aims to raise capital through an offering of common stock, warrants, and pre-funded warrants, targeting clinical trials and patent portfolio expansion.
NASDAQ
BBLG
Bone Biologics CORP
S-1: Bone Biologics Eyes $10.375 Million Capital Raise Through Stock and Warrant Offering
Bone Biologics Corporation is seeking to raise capital through a public offering of common stock, pre-funded warrants, and common warrants, aiming to fund clinical trials and extend its patent portfolio.